Incident glaucoma and ocular hypertension after periocular and intravitreal steroid injections: a claims-based analysis.
Jesse L BerryKaty C LiuDivakar GuptaDilraj S GrewalJoshua HornsBarbara M WirostkoBrian C StaggPublished in: BMJ open ophthalmology (2023)
Patients receiving ocular steroid injections are at risk of developing glaucoma/OHT, even with no prior glaucoma/OHT diagnosis or treatment. Patients should be closely monitored for the development of glaucoma following ocular steroid injections, particularly in the setting of intravitreal and/or repeated steroid administration.
Keyphrases
- optic nerve
- optical coherence tomography
- platelet rich plasma
- end stage renal disease
- vascular endothelial growth factor
- ultrasound guided
- diabetic retinopathy
- blood pressure
- ejection fraction
- newly diagnosed
- cataract surgery
- cardiovascular disease
- peritoneal dialysis
- chronic kidney disease
- prognostic factors
- type diabetes
- patient reported outcomes
- data analysis
- smoking cessation
- arterial hypertension